Mobile Technologies for Substance Use Disorders

N/A

Recruiting

Led By Hans Morefield

Research Sponsored by Chess Mobile Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-month, 6 month

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to study the effectiveness of a new version of an online intervention for individuals with moderate to high risk drug or alcohol use or Substance Use Disorder. The study will compare this new intervention with the

Who is the study for?

This trial is for adults over 18 receiving primary care in Western Michigan who have a substance-specific NIDA Modified Assist score of 27 or greater, indicating moderate to high risk drug or alcohol use.

What is being tested?

The study tests the effectiveness of an enhanced CHESS Health eIntervention versus standard treatment (SBIRT/TAU) in reducing substance use and improving treatment enrollment among those at moderate to high risk for Substance Use Disorders.

What are the potential side effects?

Since this trial involves behavioral interventions and not medications, traditional side effects are not applicable. However, participants may experience discomfort discussing personal substance use.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-month, 6 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-month, 6 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month, 6 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Contemplation ladder

Demographics

Healthcare utilization

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: SBIRT/eIntervention those assessed with high risk.Experimental Treatment1 Intervention

Subjects assigned to this condition will be instructed by the research assistant in how to download and use the eIntervention app, which they will be free to use as they like for the duration of the study. The app will contain a personalized suite of programs and activities. Unlike the TAU condition, the patient's referral to treatment would be managed through eIntervention. For example, the app will show the patient their referral details (if a referral to treatment was made), including details on the provider, referred services, and contact information, and will offer them videos of peers and professionals educating them on addiction, treatment, and sharing personal stories of recovery.

Group II: SBIRT/eIntervention for those with moderate risk drug or alcohol useExperimental Treatment1 Intervention

Group III: SBIRT/TAU for those with moderate risk drug or alcohol useActive Control1 Intervention

This moderate risk group will receive the standard Screening and Brief Intervention Treatment (SBIRT) along with Treatment as Usual (TAU) at the clinic.

Group IV: SBIRT/TAU for those assessed with high risk.Active Control1 Intervention

This high risk group will receive the standard Screening and Brief Intervention Treatment (SBIRT) along with Treatment as Usual (TAU) at the clinic.

Do I qualify?Apply below to find out